These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27384952)

  • 1. Management of women with a hereditary predisposition for breast cancer.
    Jatoi I; Benson JR
    Future Oncol; 2016 Oct; 12(19):2277-88. PubMed ID: 27384952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of women who have a genetic predisposition for breast cancer.
    Jatoi I; Anderson WF
    Surg Clin North Am; 2008 Aug; 88(4):845-61, vii-viii. PubMed ID: 18672143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management options elected by women after testing positive for a BRCA mutation.
    Garcia C; Wendt J; Lyon L; Jones J; Littell RD; Armstrong MA; Raine-Bennett T; Powell CB
    Gynecol Oncol; 2014 Feb; 132(2):428-33. PubMed ID: 24355485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
    Jatoi I
    Eur J Breast Health; 2018 Oct; 14(4):189-193. PubMed ID: 30288491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited genetic susceptibility to breast cancer.
    Chang-Claude J
    IARC Sci Publ; 2001; 154():177-90. PubMed ID: 11220657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
    Evans DG; Lalloo F; Hopwood P; Maurice A; Baildam A; Brain A; Barr L; Howell A
    Eur J Surg Oncol; 2005 Dec; 31(10):1112-8. PubMed ID: 16005602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
    Calderon-Margalit R; Paltiel O
    Int J Cancer; 2004 Nov; 112(3):357-64. PubMed ID: 15382059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of hereditary breast cancer.
    Rodriquez E; Domchek SM
    Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing strategies for intervention and prevention in hereditary breast cancer.
    Weber BL; Giusti RM; Liu ET
    J Natl Cancer Inst Monogr; 1995; (17):99-102. PubMed ID: 8573465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
    Kramer JL; Velazquez IA; Chen BE; Rosenberg PS; Struewing JP; Greene MH
    J Clin Oncol; 2005 Dec; 23(34):8629-35. PubMed ID: 16314625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the BRCA mutation carrier or high-risk patient.
    Bordeleau LJ; Lipa JE; Neligan PC
    Clin Plast Surg; 2007 Jan; 34(1):15-27; abstract v. PubMed ID: 17307068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition syndromes and their management.
    Euhus DM; Robinson L
    Surg Clin North Am; 2013 Apr; 93(2):341-62. PubMed ID: 23464690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
    Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
    Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial breast and ovarian cancers.
    Arai M; Utsunomiya J; Miki Y
    Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.